ID: ALA568933

Max Phase: Preclinical

Molecular Formula: C15H16ClN3O2S

Molecular Weight: 337.83

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=S(=O)(c1ccc(Cl)cc1)N1C2CCCC1c1cn[nH]c1C2

Standard InChI:  InChI=1S/C15H16ClN3O2S/c16-10-4-6-12(7-5-10)22(20,21)19-11-2-1-3-15(19)13-9-17-18-14(13)8-11/h4-7,9,11,15H,1-3,8H2,(H,17,18)

Standard InChI Key:  KRMWCISIWFTDOJ-UHFFFAOYSA-N

Associated Targets(Human)

Liver microsomes 16955 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Gamma-secretase 4915 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rattus norvegicus 775804 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Plasma 6361 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Cerebral cortex 16 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mus musculus 284745 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Liver 8163 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 337.83Molecular Weight (Monoisotopic): 337.0652AlogP: 2.90#Rotatable Bonds: 2
Polar Surface Area: 66.06Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.88CX Basic pKa: 2.29CX LogP: 2.36CX LogD: 2.36
Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.92Np Likeness Score: -1.35

References

1. Bowers S, Probst GD, Truong AP, Hom RK, Konradi AW, Sham HL, Garofalo AW, Wong K, Goldbach E, Quinn KP, Sauer JM, Wallace W, Nguyen L, Hemphill SS, Bova MP, Basi GS..  (2009)  N-Bridged bicyclic sulfonamides as inhibitors of gamma-secretase.,  19  (24): [PMID:19879755] [10.1016/j.bmcl.2009.10.060]
2. Mattson MN, Neitzel ML, Quincy DA, Semko CM, Garofalo AW, Keim PS, Konradi AW, Pleiss MA, Sham HL, Brigham EF, Goldbach EG, Zhang H, Sauer JM, Basi GS..  (2010)  Discovery of sulfonamide-pyrazole gamma-secretase inhibitors.,  20  (7): [PMID:20206516] [10.1016/j.bmcl.2010.02.050]
3. Mattson MN, Neitzel ML, Quincy DA, Semko CM, Garofalo AW, Keim PS, Konradi AW, Pleiss MA, Sham HL, Brigham EF, Goldbach EG, Zhang H, Sauer JM, Basi GS..  (2010)  Discovery of sulfonamide-pyrazole gamma-secretase inhibitors.,  20  (7): [PMID:20206516] [10.1016/j.bmcl.2010.02.050]
4. Aubele DL, Truong AP, Dressen DB, Probst GD, Bowers S, Mattson MN, Semko CM, Sun M, Garofalo AW, Konradi AW, Sham HL, Zmolek W, Wong K, Goldbach E, Quinn KP, Sauer JM, Brigham EF, Wallace W, Nguyen L, Bova MP, Hemphill SS, Basi G..  (2011)  Design, synthesis and structure-activity relationship of novel [3.3.1] bicyclic sulfonamide-pyrazoles as potent γ-secretase inhibitors.,  21  (19): [PMID:21885276] [10.1016/j.bmcl.2011.08.008]

Source